Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Dec-11 9:01 AM View:  | Bondurant Stuart Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 21,479 | $33.25 | $714,177.00 | (100%) 21.48K to 0 | < 1% |
| 06-Dec-11 2:53 PM View: | Hill Raymond H Chief Executive Officer Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 30,000 | -- | -- | (100%) 30.0K to 0 | |
| 06-Dec-11 9:19 AM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 214,750 | $33.25 | $7,140,440.00 | (45%) 478.06K to 263.31K | < 1% |
| 06-Dec-11 9:10 AM View: | Eshelman Fredric N Executive Chairman Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 6,984,740 | $33.25 | $232,243,008.00 | (94%) 7.39M to 407.44K | < 1% |
| 06-Dec-11 9:20 AM View: | Richardson William W Sr. VP Global Bus. Development | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 1,144 | $33.25 | $38,038.00 | (100%) 1.14K to 0 | < 1% |
| 06-Dec-11 9:07 AM View: | Darazsdi Daniel G Chief Financial Officer | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 13,195 | $33.25 | $438,734.00 | (100%) 13.2K to 0 | < 1% |
| 06-Dec-11 9:24 AM View: | Snyderman Ralph Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 1,139 | $33.25 | $37,871.80 | (100%) 1.14K to 0 | < 1% |
| 06-Dec-11 9:17 AM View: | Magnuson Terry Director 10% Owner | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 17,633 | $33.25 | $586,297.00 | (100%) 17.63K to 0 | < 1% |
| 06-Dec-11 9:16 AM View: | Wilkinson Michael O. Chief Information Officer | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 2,362 | $33.25 | $78,536.50 | (100%) 2.36K to 0 | < 1% |
| 06-Dec-11 9:19 AM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 263,313 | $33.25 | $8,755,160.00 | (100%) 263.31K to 0 | < 1% |
| 06-Dec-11 9:10 AM View: | Eshelman Fredric N Executive Chairman Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 407,443 | $33.25 | $13,547,500.00 | (100%) 407.44K to 0 | < 1% |
| 06-Dec-11 9:06 AM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 45 | $33.25 | $1,496.25 | (100%) 45 to 0 | < 1% |
| 06-Dec-11 9:22 AM View: | Sharbaugh William J Chief Operating Officer | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 13,906 | $33.25 | $462,374.00 | (100%) 13.91K to 0 | < 1% |
| 06-Dec-11 9:11 AM View: | Frank Fred Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 72,565 | $33.25 | $2,412,790.00 | (100%) 72.56K to 0 | < 1% |
| 06-Dec-11 9:14 AM View: | Ingram Robert Alexander Director | Pharmaceutical Product Deve... (PPDI) | 05-Dec-11 | Disposition | 1,139 | $33.25 | $37,871.80 | (100%) 1.14K to 0 | < 1% |
| 06-Dec-11 9:16 AM View: | Wilkinson Michael O. Chief Information Officer | Pharmaceutical Product Deve... (PPDI) | 22-Nov-11 | Acquisition | 280 | $24.98 | $6,994.40 | 13% 2.08K to 2.36K | |
| 06-Dec-11 9:20 AM View: | Richardson William W Sr. VP Global Bus. Development | Pharmaceutical Product Deve... (PPDI) | 22-Nov-11 | Acquisition | 90 | $24.98 | $2,248.20 | 9% 1.05K to 1.14K | |
| 06-Dec-11 9:07 AM View: | Darazsdi Daniel G Chief Financial Officer | Pharmaceutical Product Deve... (PPDI) | 22-Nov-11 | Acquisition | 323 | $24.98 | $8,068.54 | 3% 12.87K to 13.2K | |
| 06-Dec-11 9:06 AM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 22-Nov-11 | Acquisition | 20 | $24.98 | $499.60 | 80% 25 to 45 | |
| 06-Dec-11 9:22 AM View: | Sharbaugh William J Chief Operating Officer | Pharmaceutical Product Deve... (PPDI) | 22-Nov-11 | Acquisition | 324 | $24.98 | $8,093.52 | 2% 13.58K to 13.91K | |
| 20-Sep-11 4:28 PM View: | Hill Raymond H Chief Executive Officer Director | Pharmaceutical Product Deve... (PPDI) | 16-Sep-11 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 06-Jul-11 3:45 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 30-Jun-11 | Acquisition | 24 | $24.16 | $579.84 | 100% 0 to 24 | |
| 06-Jul-11 3:50 PM View: | Sharbaugh William J Chief Operating Officer | Pharmaceutical Product Deve... (PPDI) | 30-Jun-11 | Acquisition | 589 | $24.16 | $14,230.20 | 5% 12.94K to 13.53K | |
| 06-Jul-11 3:51 PM View: | Wilkinson Michael O. Chief Information Officer | Pharmaceutical Product Deve... (PPDI) | 30-Jun-11 | Acquisition | 347 | $24.16 | $8,383.52 | 20% 1.7K to 2.05K | |
| 06-Jul-11 3:48 PM View: | Richardson William W Sr. VP Global Bus. Development | Pharmaceutical Product Deve... (PPDI) | 30-Jun-11 | Acquisition | 112 | $24.16 | $2,705.92 | 12% 0.93K to 1.04K | |
| 06-Jul-11 3:46 PM View: | Darazsdi Daniel G Chief Financial Officer | Pharmaceutical Product Deve... (PPDI) | 30-Jun-11 | Acquisition | 401 | $24.16 | $9,688.16 | 3% 12.43K to 12.83K | |
| 06-Jul-11 3:43 PM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 23-Jun-11 | Gift | 115,500 | -- | -- | (22%) 529.14K to 413.64K | |
| 27-May-11 2:07 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 27-May-11 | Option Exercise | 5,659 | $20.42 | $115,560.00 | 100% 0 to 5.66K | |
| 27-May-11 2:07 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 27-May-11 | Market Option Sale | 5,659 | $28.70 | $162,413.00 | (100%) 5.66K to 0 | 9% |
| 27-May-11 2:07 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 26-May-11 | Option Exercise | 100 | $19.94 | $1,994.00 | 100% 0 to 100 | |
| 27-May-11 2:07 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 26-May-11 | Market Option Sale | 100 | $28.70 | $2,870.00 | (100%) 100 to 0 | 9% |
| 23-May-11 3:36 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 20-May-11 | Option Exercise | 600 | $20.10 | $12,059.40 | 100% 0 to 0.6K | |
| 23-May-11 3:36 PM View: | Colvin Paul EVP--Clinical Development | Pharmaceutical Product Deve... (PPDI) | 20-May-11 | Market Option Sale | 600 | $29.01 | $17,406.00 | (100%) 0.6K to 0 | 10% |
| 19-May-11 3:35 PM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | < 1% 586.24K to 587.38K | |
| 06-Dec-11 9:04 AM View: | Bryson Vaughn D Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Disposition | 1,139 | $33.25 | $37,871.80 | (100%) 1.14K to 0 | |
| 19-May-11 3:38 PM View: | Snyderman Ralph Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | 100% 0 to 1.14K | |
| 19-May-11 3:36 PM View: | Magnuson Terry Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | 7% 16.49K to 17.63K | |
| 19-May-11 3:31 PM View: | Frank Fred Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | 2% 71.43K to 72.56K | |
| 19-May-11 3:33 PM View: | Ingram Robert Alexander Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | 100% 0 to 1.14K | |
| 19-May-11 3:23 PM View: | Bondurant Stuart Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | 6% 20.34K to 21.48K | |
| 19-May-11 3:26 PM View: | Bryson Vaughn D Director | Pharmaceutical Product Deve... (PPDI) | 18-May-11 | Grant | 1,139 | -- | -- | 100% 0 to 1.14K | |
| 04-May-11 3:42 PM View: | Hartman Judd General Counsel | Pharmaceutical Product Deve... (PPDI) | 03-May-11 | Market Option Sale | 112,476 | $30.23 | $3,400,150.00 | (100%) 112.48K to 0 | 14% |
| 04-May-11 3:42 PM View: | Hartman Judd General Counsel | Pharmaceutical Product Deve... (PPDI) | 03-May-11 | Option Exercise | 112,476 | $20.41 | $2,295,460.00 | 100% 0 to 112.48K | |
| 06-Dec-11 9:10 AM View: | Eshelman Fredric N Executive Chairman Director | Pharmaceutical Product Deve... (PPDI) | 14-Apr-11 | Acquisition (other) | 15,000 | -- | -- | < 1% 7.39M to 7.41M | |
| 06-Dec-11 9:10 AM View: | Eshelman Fredric N Executive Chairman Director | Pharmaceutical Product Deve... (PPDI) | 14-Apr-11 | Disposition (other) | 15,000 | -- | -- | (< 1%) 7.41M to 7.39M | |
| 19-May-11 3:29 PM View: | Eshelman Fredric N Executive Chairman Director | Pharmaceutical Product Deve... (PPDI) | 07-Apr-11 | Gift | 83,000 | -- | -- | (1%) 7.48M to 7.39M | |
| 19-May-11 3:35 PM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 05-Apr-11 | Gift | 5,000 | -- | -- | < 1% 581.02K to 586.02K | |
| 19-May-11 3:35 PM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 14-Mar-11 | Disposition (other) | 65,832 | -- | -- | (10%) 646.85K to 581.02K | |
| 19-May-11 3:35 PM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 14-Mar-11 | Acquisition (other) | 32,916 | -- | -- | 6% 581.02K to 613.93K | |
| 19-May-11 3:35 PM View: | Mario Ernest Director | Pharmaceutical Product Deve... (PPDI) | 14-Mar-11 | Acquisition (other) | 32,916 | -- | -- | 5% 613.93K to 646.85K |
